Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000543280 | SCV000634041 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-10-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002527747 | SCV003587553 | uncertain significance | Inborn genetic diseases | 2021-11-15 | criteria provided, single submitter | clinical testing | The c.1232C>T (p.P411L) alteration is located in exon 11 (coding exon 11) of the KCNQ2 gene. This alteration results from a C to T substitution at nucleotide position 1232, causing the proline (P) at amino acid position 411 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV004808753 | SCV005432671 | uncertain significance | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing |